These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 25748073)
1. Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor. Flacco ME; Manzoli L; Boccia S; Capasso L; Aleksovska K; Rosso A; Scaioli G; De Vito C; Siliquini R; Villari P; Ioannidis JP J Clin Epidemiol; 2015 Jul; 68(7):811-20. PubMed ID: 25748073 [TBL] [Abstract][Full Text] [Related]
2. Industry sponsorship and selection of comparators in randomized clinical trials. Lathyris DN; Patsopoulos NA; Salanti G; Ioannidis JP Eur J Clin Invest; 2010 Feb; 40(2):172-82. PubMed ID: 20050879 [TBL] [Abstract][Full Text] [Related]
3. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others. Bero L; Oostvogel F; Bacchetti P; Lee K PLoS Med; 2007 Jun; 4(6):e184. PubMed ID: 17550302 [TBL] [Abstract][Full Text] [Related]
4. Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials. Pang WK; Yeter KC; Torralba KD; Spencer HJ; Khan NA Int J Rheum Dis; 2015 Jul; 18(6):606-15. PubMed ID: 26012523 [TBL] [Abstract][Full Text] [Related]
5. Spine device clinical trials: design and sponsorship. Cher DJ; Capobianco RA Spine J; 2015 May; 15(5):1133-40. PubMed ID: 25637470 [TBL] [Abstract][Full Text] [Related]
6. Disclosure of competing financial interests and role of sponsors in phase III cancer trials. Tuech JJ; Moutel G; Pessaux P; Thoma V; Schraub S; Herve C Eur J Cancer; 2005 Oct; 41(15):2237-40. PubMed ID: 16214044 [TBL] [Abstract][Full Text] [Related]
7. Sponsorship, antidepressant dose, and outcome in major depressive disorder: meta-analysis of randomized controlled trials. Sinyor M; Schaffer A; Smart KA; Levitt AJ; Lanctôt KL; Grysman NH J Clin Psychiatry; 2012 Feb; 73(2):e277-87. PubMed ID: 22401489 [TBL] [Abstract][Full Text] [Related]
8. Sponsors' participation in conduct and reporting of industry trials: a descriptive study. Lundh A; Krogsbøll LT; Gøtzsche PC Trials; 2012 Aug; 13():146. PubMed ID: 22920226 [TBL] [Abstract][Full Text] [Related]
9. The uncertainty principle and industry-sponsored research. Djulbegovic B; Lacevic M; Cantor A; Fields KK; Bennett CL; Adams JR; Kuderer NM; Lyman GH Lancet; 2000 Aug; 356(9230):635-8. PubMed ID: 10968436 [TBL] [Abstract][Full Text] [Related]
10. A Review of Industry Funding in Randomized Controlled Trials Published in the Neurosurgical Literature-The Elephant in the Room. Khan NR; Saad H; Oravec CS; Rossi N; Nguyen V; Venable GT; Lillard JC; Patel P; Taylor DR; Vaughn BN; Kondziolka D; Barker FG; Michael LM; Klimo P Neurosurgery; 2018 Nov; 83(5):890-897. PubMed ID: 29462484 [TBL] [Abstract][Full Text] [Related]
11. Outcomes, Interventions and Funding in Randomised Research Published in High-Impact Journals. Grey P; Grey A; Bolland MJ Trials; 2018 Oct; 19(1):592. PubMed ID: 30373636 [TBL] [Abstract][Full Text] [Related]
12. The influence of industry sponsorship on the reporting of subgroup analyses within phase III randomised controlled trials in gastrointestinal oncology. Barton S; Peckitt C; Sclafani F; Cunningham D; Chau I Eur J Cancer; 2015 Dec; 51(18):2732-9. PubMed ID: 26608121 [TBL] [Abstract][Full Text] [Related]
13. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079 [TBL] [Abstract][Full Text] [Related]
14. Influence of study sponsorship on head and neck cancer randomized trial results. Sun GH; Houlton JJ; MacEachern MP; Bradford CR; Hayward RA Head Neck; 2013 Oct; 35(10):1515-20. PubMed ID: 22987508 [TBL] [Abstract][Full Text] [Related]
15. Self-declared stock ownership and association with positive trial outcome in randomized controlled trials with binary outcomes published in general medical journals: a cross-sectional study. Falk Delgado A; Falk Delgado A Trials; 2017 Jul; 18(1):354. PubMed ID: 28747226 [TBL] [Abstract][Full Text] [Related]
16. Association of industry sponsorship to published outcomes in gastrointestinal clinical research. Brown A; Kraft D; Schmitz SM; Sharpless V; Martin C; Shah R; Shaheen NJ Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1445-51. PubMed ID: 17101295 [TBL] [Abstract][Full Text] [Related]
17. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? Als-Nielsen B; Chen W; Gluud C; Kjaergard LL JAMA; 2003 Aug; 290(7):921-8. PubMed ID: 12928469 [TBL] [Abstract][Full Text] [Related]
18. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Bhandari M; Busse JW; Jackowski D; Montori VM; Schünemann H; Sprague S; Mears D; Schemitsch EH; Heels-Ansdell D; Devereaux PJ CMAJ; 2004 Feb; 170(4):477-80. PubMed ID: 14970094 [TBL] [Abstract][Full Text] [Related]
19. The association between funding by commercial interests and study outcome in randomized controlled drug trials. Yaphe J; Edman R; Knishkowy B; Herman J Fam Pract; 2001 Dec; 18(6):565-8. PubMed ID: 11739337 [TBL] [Abstract][Full Text] [Related]
20. Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study. Montedori A; Bonacini MI; Casazza G; Luchetta ML; Duca P; Cozzolino F; Abraha I Trials; 2011 Feb; 12():58. PubMed ID: 21356072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]